摘要The transcriptional factor p53 activates the expression of a myriad of target genes involving a complicated signalling network,resulting in various cellular outcomes,such as growth arrest,senescence,apoptosis,and metabolic changes,and leading to consequent suppression of tumour growth and progression.Because of the profoundly adverse effect of p53 on growth and prolifer ation of cancer cells,several feedback mechanisms have been employed by the cells to constrain p53 activity.Two major antagonists MDM2 and MDMX (the long forms) are transcriptionally induced by p53,but in return block p53 activity,forming a negative feedback circuit and rendering chemoresistance of several cancer cells.However,they are not alone,as cancer cells also employ other proteins encoded by p53 target genes to inhibit p53 activity at transcriptional,translational,and posttranslational levels.This essay is thus composed to review a recent progress in understanding the mechanisms for how cancer cells hijack the p53 autoregulation by these proteins for their growth advantage and to discuss the clinical implications of these autoregulatory loops.